Trademark: 76259611
Word
SYNERGENES
Status
Dead
Status Code
606
Status Date
Wednesday, June 11, 2003
Serial Number
76259611
Mark Type
5000
Filing Date
Friday, May 18, 2001
Published for Opposition
Tuesday, September 17, 2002
Abandoned Date
Wednesday, June 11, 2003

Trademark Owner History
EPIGENESIS Pharmaceuticals, Inc. - Owner At Publication

Classifications
42 Scientific and research services in the field of genetics and gene therapy, namely research to identify synergistic relationships between genetic and protein targets in multifactorial diseases, for use in testing preventative and therapeutic treatments for respiratory, airway and pulmonary diseases, renal damage and failure associated with ischemia, and the side effects associated with administration of adenosine and other drugs and for treating supraventricular tachycardia and in adenosine stress tests, infantile respiratory distress syndrome, pain, cystic, fibrosis, allergic rhinitis, bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease, as well as cancers namely, leukemias, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., and other metastatic cancers, in lungs, breast and prostate, and central nervous system diseases

Trademark Events
Sep 10, 2003
Abandonment - No Use Statement Filed
Dec 10, 2002
Noa Mailed - Sou Required From Applicant
Sep 17, 2002
Published For Opposition
Aug 28, 2002
Notice Of Publication
Jun 12, 2002
Approved For Pub - Principal Register
Jun 5, 2002
Examiners Amendment Mailed
May 10, 2002
Correspondence Received In Law Office
May 21, 2002
Reinstated
Apr 22, 2002
Abandonment - Failure To Respond Or Late Response
Apr 22, 2002
Assigned To Examiner
Jun 27, 2001
Non-Final Action Mailed
Jun 8, 2001
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24